Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
| ▸ | RAB9A | P51151 | 2/20 | 0.35 |
| ▸ | PPARA | Q07869 | 8/20 | 0.35 |
| ▸ | PPARG | P37231 | 8/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23965605 | 0.90 | KDM1A (0.32) | HPGDL3MBTL1LMNAMAPK1HTT | |
| SCHEMBL23978133 | 0.85 | HPGD (0.39) | HPGDL3MBTL1LMNAMAPK1HTT | |
| SCHEMBL23965598 | 0.79 | MAPT (0.37) | HPGDL3MBTL1LMNAHIF1ANPC1 | |
| SCHEMBL23969493 | 0.78 | SCN1A (0.31) | — | |
| SCHEMBL23969524 | 0.78 | S1PR1 (0.37) | HPGDL3MBTL1LMNAHIF1ANPC1 | |
| SCHEMBL23971689 | 0.78 | HIF1A (0.54) | HPGDL3MBTL1LMNAMAPK1HTT | |
| SCHEMBL23967970 | 0.77 | S1PR1 (0.41) | HPGDLMNAHIF1ANPC1RAB9A | |
| SCHEMBL23965585 | 0.77 | GAA (0.41) | HPGDL3MBTL1LMNAHIF1ANPC1 | |
| SCHEMBL23978207 | 0.76 | SMN1; SMN2 (0.38) | LMNAHIF1ANPC1RAB9APPARA | |
| SCHEMBL25552201 | 0.76 | HIF1A (0.39) | L3MBTL1LMNAHIF1ANPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3903583-A1 | USE OF STROBILURIN TYPE COMPOUNDS FOR COMBATING PHYTOPATHOGENIC FUNGI CONTAINING AN AMINO ACID SUBSTITUTION F129L IN THE MITOCHONDRIAL CYTOCHROME B PROTEIN CONFERRING RESISTANCE TO QO INHIBITORS III | BASF SE (DE) | 2021-11-03 | — | — | EP | disclosed |